CXCL-13 als Biomarker in der Diagnostik der Neuroborreliose

Medicine and Dentistry

• Neuroborreliosis 100%
• Diagnosis 58%
• Patient 58%
• Biological Marker 16%
• Antibody 8%
• Sensitivity and Specificity 8%
• CXCL13 Chemokine 8%
• Tuberculosis 8%
• Borrelia burgdorferi 8%
• Syphilis 8%
• Clinically Isolated Syndrome 8%
• Paraneoplastic Syndrome 8%
• Analysis 8%
• Neurology 8%

Neuroscience

• Intrathecal 16%
• Antibodies 8%
• CXCL13 Chemokine 8%
• Tuberculosis 8%
• Syphilis 8%
• Demyelinating Disease 8%
• Paraneoplastic Syndrome 8%

Immunology and Microbiology

• Monospecific Antibody 8%
• Electric Potential 8%
• CXCL13 Chemokine 8%
• Paraneoplastic Syndrome 8%
• Borrelia burgdorferi 8%